Relationship Between Topotecan Systemic Exposure and Tumor Response in Human Neuroblastoma Xenografts-Reference-Cited by-同舟云学术

Relationship Between Topotecan Systemic Exposure and Tumor Response in Human Neuroblastoma Xenografts

Published:1998-04-01 Issue:7 Volume:90 Page:505-511
ISSN:0027-8874
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Zamboni William C.,Stewart Clinton F.,Houghton Peter J.,Thompson Joyce,Santana Victor M.,Cheshire Pamela J.,Richmond Lois B.,Houghton Janet A.,Luo Xiaolong,Poquette Catherine

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/90/7/505/18048783/90-7-505.pdf

Reference22 articles.

1. Evaluation of N-(5-indanylsulfonyl)-N′-(4-chlorophenyl)-urea against xenografts of pediatric rhabdomyosarcoma;Houghton;Cancer Chemother Pharmacol,1989

2. Evaluation of 9-dimethylaminomethyl-10-hydroxycamptothecin against xenografts derived from adult and childhood solid tumors;Houghton;Cancer Chemother Pharmacol,1992

3. Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors;Houghton;Cancer Chemother Pharmacol,1995

4. Activity of 9-dimethylaminomethyl-10-hydroxycamptothecin against pediatric and adult central nervous system tumor xenografts;Friedman;Cancer Chemother Pharmacol,1994

5. Systemic exposure to topotecan related to antitumor response in human neuroblastoma xenografts;Thompson;Proc Am Assoc Cancer Res,1997

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Topotecan clearance based on a single sample and a population pharmacokinetic model: Application to a pediatric high‐risk neuroblastoma clinical trial;Pediatric Blood & Cancer;2023-09-04

2. How translational modeling in oncology needs to get the mechanism just right;Clinical and Translational Science;2021-11-12

3. Optimization of a clofarabine‐based drug combination regimen for the preclinical evaluation of pediatric acute lymphoblastic leukemia;Pediatric Blood & Cancer;2019-12-25

4. CNS penetration of the CDK4/6 inhibitor ribociclib in non-tumor bearing mice and mice bearing pediatric brain tumors;Cancer Chemotherapy and Pharmacology;2019-05-11

5. Determining success rates of the current pharmacokinetically guided dosing approach of topotecan in pediatric oncology patients;Pediatric Blood & Cancer;2018-12-11